{
    "Trade/Device Name(s)": [
        "EASYGLUCO G2 Blood Glucose Monitoring System",
        "EASYGLUCOTM G2",
        "EASYGLUCOTM Diabetes Monitoring System"
    ],
    "Submitter Information": "US Diagnostics, Inc.",
    "510(k) Number": "K061431",
    "Predicate Device Reference 510(k) Number(s)": [
        "K024194",
        "K984261",
        "K021513"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "January 12, 2007",
    "Summary Letter Received Date": "December 5, 2006",
    "Submission Date": "December 4, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Blood Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "EASYGLUCOTM Monitor"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical",
        "Dehydrogenase enzymatic reaction"
    ],
    "Methodologies": [
        "Electrochemical measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for EASYGLUCO G2 electrochemical blood glucose monitoring system for diabetes management in whole blood specimens",
    "Indications for Use Summary": "Quantitative measurement of glucose level in whole blood as an aid in monitoring the effectiveness of diabetes management in home and clinical settings; not for use with neonatal blood specimens; testing on fingertip and alternate sites (forearm, palm, calf, thigh)",
    "fda_folder": "Clinical Chemistry"
}